IQV News and Press, IQVIA Holdings Inc. From 11/21/23

2023-11-21 12:59:47 ET Summary IQVIA's revenue growth was below estimates, but adjusted EBITDA and EPS beat expectations. RDS segment showed strong demand and growth, with a stable backlog and positive indicators for FY24. TAS segment continues to face challenges, with weak qu...

IQVIA Holdings Inc. (NYSE:IQV) (the “Company”) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Borrower”), allocated a new term B loan due 2031 of approximately $1,500 million (the “New Term Loan B”), which was upsized due to lender dem...

IQVIA Holdings Inc. (NYSE:IQV) (the “Company”) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer” or “Borrower”), priced an offering of $1,250 million in aggregate principal amount of senior secured notes due 2029 (the “Note...

2023-11-14 09:43:14 ET More on IQVIA IQVIA: I Would Stay Away Until Debt Issues Are Resolved IQVIA Holdings Q3 2023 Earnings Call Transcript IQVIA Holdings 2023 Q3 - Results - Earnings Call Presentation Baird downgrades IQVIA to neutral from outperform ...

IQVIA Holdings Inc. (NYSE:IQV) (the “Company”) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer” or “Borrower”), intends to raise $500,000,000 through an offering of senior secured notes due 2029 (the “Notes”). S...

2023-11-12 06:33:20 ET Summary IQVIA is a global provider of contract research services and data analytics for the healthcare industry. The company helps clients drive healthcare forward by providing insights and solutions to improve. The Net Debt/EBITDA ratio is 4.6x, moreover, 5...

2023-11-07 03:54:37 ET Summary William von Mueffling's 13F portfolio value decreased by 6% this quarter, with 39 holdings. A new stake in Canadian Pacific was established this quarter. Stake increases in BlackRock Inc. and Beckton Dickinson, while stake decreases in S&P Gl...

IQVIA™ (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, announced that Dr. Christina Mack, chief scientific officer, has been named to the 2023 PharmaVoice 100 list. The PharmaVoice 100, an industry-acclaimed honor now i...

2023-11-02 14:43:56 ET More on IQVIA IQVIA Holdings, Inc. (IQV) Q3 2023 Earnings Call Transcript IQVIA Holdings Inc. 2023 Q3 - Results - Earnings Call Presentation IQVIA: Stock To Remain Rangebound As I Expect Weak Numbers In The Near Term IQVIA Holdings cuts...

2023-11-01 14:48:06 ET IQVIA Holdings, Inc. (IQV) Q3 2023 Earnings Conference Call November 01, 2023, 09:00 ET Company Participants Nicholas Childs - SVP, IR & Treasury Ari Bousbib - Chairman, President & CEO Ronald Bruehlman - EVP & CFO Confere...